Citizens Initiates Coverage On Ascentage Pharma Group with Market Outperform Rating, Announces Price Target of $35
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsInitiationPrice Target
Citizens analyst Silvan Turkcan initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Market Outperform rating and announces Price Target of $35.
Citizens analyst Silvan Turkcan initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Market Outperform rating and announces Price Target of $35.